We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters.
- Authors
Temesszentandrási-Ambrus, Csilla; Tóth, Szilárd; Verma, Rinkee; Bánhegyi, Péter; Szabadkai, István; Baska, Ferenc; Szántai-Kis, Csaba; Hartkoorn, Ruben C.; Lingerfelt, Mary A.; Sarkadi, Balázs; Szakács, Gergely; Őrfi, László; Nagaraja, Valakunja; Ekins, Sean; Telbisz, Ágnes
- Abstract
Drug resistant tuberculosis (TB) is a major worldwide health problem. In addition to the bacterial mechanisms, human drug transporters limiting the cellular accumulation and the pharmacological disposition of drugs also influence the efficacy of treatment. Mycobacterium tuberculosis topoisomerase-I (MtTopo-I) is a promising target for antimicrobial treatment. In our previous work we have identified several hit compounds targeting the MtTopo-I by in silico docking. Here we expand the scope of the compounds around three scaffolds associated with potent MtTopo-I inhibition. In addition to measuring the effect of newly generated compounds on MtTopo-I activity, we characterized the compounds’ antimicrobial activity, toxicity in human cells, and interactions with human multidrug transporters. Some of the newly developed MtTopo-I inhibitors have strong antimicrobial activity and do not harm mammalian cells. Moreover, our studies revealed significant human ABC drug transporter interactions for several MtTopo-I compounds that may modify their ADME-Tox parameters and cellular effects. Promising new drug candidates may be selected based on these studies for further anti-TB drug development.
- Subjects
MYCOBACTERIUM tuberculosis; DNA topoisomerase I; MULTIDRUG transporters; DRUG development; TISSUE scaffolds; THERAPEUTICS
- Publication
PLoS ONE, 2018, Vol 13, Issue 9, p1
- ISSN
1932-6203
- Publication type
Article
- DOI
10.1371/journal.pone.0202749